Chromatwist
Birmingham
About Chromatwist
Chromatwist they provide shifted organic fluorescent dyes which, when irradiated with UV light, become visible blue excitation sources. Their patented innovative molecular technology platform coupled to their modular and scalable chemistry allows the development of their fluorophores to further push the boundaries of applications in the healthcare sector through their use in bio-sensing (e.g. flow cytometry) and bio-imaging (e.g. multiphoton microscopy).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Grant (Nov 2024)
- Website: chromatwist.com
- Phone: [email protected]
Industries & Categories
Advanced Materials, Chemical, Manufacturing, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/chromatwist-146130 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.